Triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, is associated with a lower disease-free and overall survival compared to the other subtypes [2]. Here, ESR1 is linked to triple-negative breast carcinoma.